Thomas C. Reynolds, Chief Medical Officer at SEATTLE GENETICS INC /WA (SGEN), sold 40,000 shares at $25.50 ($1.0M) on 2012-11-29, disclosed to the SEC on 2012-12-03.
Open-market sale of $1.0M SGEN by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.25 | 10,000 | $253K | 24.8% |
| 2 | $25.46 | 9,675 | $246K | 24.2% |
| 3 | $25.50 | 325 | $8K | 0.8% |
| 4 | $25.50 | 523 | $13K | 1.3% |
| 5 | $25.50 | 9,477 | $242K | 23.8% |
| 6 | $25.45 | 10,000 |
| $255K |
| 25.0% |
| Total | $25.42 avg | 40,000 | $1.0M | 100% |
| Filing → |
| SGEN | SELL | 2013-01-17 | $3.5M | — | Filing → |
| SGEN | SELL | 2012-12-10 | $1.7M | — | Filing → |
| SGEN | SELL | 2012-12-06 | $1.0M | — | Filing → |